United States Anthrax Treatment Market Size & Outlook, 2025-2033


United States Anthrax Treatment Market Insights

  • As per Reed Intelligence insights, the United States Anthrax Treatment Market stood at USD 117.55 Million in 2024 and is anticipated to grow to USD 192.15 Million by 2033.
  • The United States market is expected to advance at a CAGR of 5.62% from 2026 through 2033.
  • In 2024, Cutaneous Anthrax accounted for the highest share of the By Disease Type market size.
  • During the forecast period, Inhalation Anthrax is set to register the highest growth, making it the most lucrative By Disease Type segment.

Other Key Findings


  • As of 2024, United States held 27.82% of the global Anthrax Treatment Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Anthrax Treatment Market.
  • In North America, United States is expected to lead the regional Anthrax Treatment Market size by 2033.
  • United States will remain the fastest-growing market in North America, reaching USD 192.28 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 117.55 Million
Market Size In 2033 USD 192.15 Million
Largest segment Cutaneous Anthrax
Units Revenue in USD Million
CAGR 5.62% (2025-2033)
Segmnetation Covered
By Disease Type
  1. Cutaneous Anthrax
  2. Inhalation Anthrax
  3. Gastrointestinal Anthrax
  4. Injection Anthrax
By Treatment Type
  1. Antibiotics
  2. Immunoglobulins
  3. Others
By Route of Administration
  1. Parenteral
  2. Oral
By End-User
  1. Hospitals
  2. Clinics
  3. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports